Expertise in
106
conditions
Expertise in
106
conditions
AdventHealth Medical Group Oncology & Hematology At Orlando
2501 N Orange Ave Ste 689, 
Orlando, FL 

Overview

Tarek Mekhail is an Oncologist practicing medicine in Orlando, Florida.

Dr. Mekhail is highly rated in 106 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 48 peer reviewed articles and participating in 9 clinical trials. Dr. Mekhail is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in OH

Hospital Affiliations

Adventhealth Orlando
Adventhealth Fish Memorial
Adventhealth Daytona Beach
Adventhealth Waterman
Adventhealth Deland

Languages Spoken

English
Arabic
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Card System
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
  • PPO
MetLife
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

AdventHealth Medical Group Oncology & Hematology at Orlando
2501 N Orange Ave Ste 689, Orlando, FL 32804

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

A Phase 2 Study of VLS-101 in Patients With Solid Tumors
View 8 Less Clinical Trials

48 Total Publications

Predictors of Enrolment in a Transoral Surgical Trial for HPV-Related Oropharyngeal Carcinoma.
Similar Doctors
Expertise in
19
conditions
Expertise in
19
conditions
Referral may be required

AHMG Oncology And Hematology At Orlando

2501 N Orange Ave Ste 689, 
Orlando, FL 
 (0.1 miles away)
Languages Spoken:
English, Hindi
Accepting New Patients
Offers Telehealth

Guru Sonpavde is an Oncologist practicing medicine in Orlando, Florida. Dr. Sonpavde is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Orchiectomy, and Nephrectomy. Dr. Sonpavde is currently accepting new patients.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required

AdventHealth Medical Group Oncology & Hematology At Orlando

2501 N Orange Ave Ste 689, 
Orlando, FL 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Mark Socinski is an Oncologist practicing medicine in Orlando, Florida. Dr. Socinski is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Lung Adenocarcinoma, and Tissue Biopsy. Dr. Socinski is currently accepting new patients.

Expertise in
25
conditions
Gynecologic Oncology | Oncology
Expertise in
25
conditions
Gynecologic Oncology | Oncology
Referral may be required

AdventHealth Medical Group GYN Oncology At Orlando

2501 N Orange Ave Ste 786, 
Orlando, FL 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Robert Holloway is a Gynecologic Oncologist and an Oncologist practicing medicine in Orlando, Florida. Dr. Holloway is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Hysterectomy, and Lymphadenectomy. Dr. Holloway is currently accepting new patients.

Expertise in
21
conditions
Expertise in
21
conditions
Referral may be required

AdventHealth Medical Group Neuro Oncology At

2501 N Orange Ave Ste 286, 
Orlando, FL 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Herbert Newton is an Oncologist practicing medicine in Orlando, Florida. Dr. Newton is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Glioma, Brain Tumor, Astrocytoma, and Glioblastoma. Dr. Newton is currently accepting new patients.

Expertise in
17
conditions
Hematology | Oncology
Expertise in
17
conditions
Hematology | Oncology
Referral may be required

Orlando Health Cancer Institute - Downtown Orlando

1400 S. Orange Ave., 
Orlando, FL 
 (3.8 miles away)
Languages Spoken:
English, Arabic, French, Spanish
Accepting New Patients
Offers Telehealth

Dr. Jad Chahoud is the chief scientific and innovation officer with Orlando Health Cancer Institute, where he drives the organization's vision for research excellence and technology-enabled innovation. In this role, he leads strategic initiatives to advance clinical trials, strengthen research infrastructure and integrate cutting-edge technologies that position Orlando Health as a national leader in patient-centered care and scientific advancement. He also is a board-certified medical oncologist and expert in treating advanced genitourinary cancers. Dr. Chahoud is passionate about transforming research operations through AI-enabled clinical trial systems and expanding patient access to groundbreaking therapies across Florida. Dr. Chahoud's Training Dr. Chahoud received his medical training at Lebanese University in Beirut, Lebanon. He completed an internal medicine residency at the University of Texas Health Science Center in Houston and a hematology and medical oncology fellowship at the University of Texas MD Anderson Cancer Center in Houston. He also earned a Master of Public Health and Master of Health Administration (MPH-MHA) from the University of Texas. About Dr. Chahoud Dr. Chahoud is board certified in hematology, medical oncology and internal medicine by the American Board of Internal Medicine. His professional memberships include the American Society of Clinical Oncology, American Association of Cancer Research, European Society of Medical Oncology and Society for Immunotherapy of Cancer. A nationally recognized clinician, scientist and expert in advanced genitourinary cancers, Dr. Chahoud has led numerous first-in-human and investigator-initiated studies and is internationally known for his research on renal cell carcinoma and rare malignancies. His work has been published in numerous top-tier medical journals, including The Lancet, Journal of Clinical Oncology and Nature. Outside of work, he enjoys spending time with family. Dr. Chahoud is fluent in English, Spanish, French and Arabic. Dr. Chahoud is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Penile Cancer, Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Penectomy, and Nephrectomy. Dr. Chahoud is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine. Dr. Chahoud is currently accepting new patients.

Expertise in
19
conditions
Neurology | Hematology | Oncology
Expertise in
19
conditions
Neurology | Hematology | Oncology
Referral may be required

Orlando Health Cancer Institute - Downtown Orlando

1400 S. Orange Ave., 
Orlando, FL 
 (3.8 miles away)
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Dr. Alfredo Voloschin is a board-certified neurologist at the Orlando Health Cancer Institute and is sub-specialized in neuro-oncology, board-certified by the United Council for Neurologic Subspecialties. He treats patients with central nervous system malignancies as well as neurological complications of cancer. He has a particular interest in clinical trials for patients with gliomas and primary central nervous system lymphomas. His specialties include: Cancer in the spinal fluid, or leptomeningeal disease Toxicities from chemotherapy or radiation therapy Glioblastomas Grade 2, 3 and 4 gliomas Oligodendrogliomas Ependymomas Clinical trials Dr. Voloschin brings more than 20 years of experience, and he is a diplomate of the American Board of Psychiatry and Neurology. Dr. Voloschin's Training Dr. Voloschin received his medical training from the Universidad Nacional de Buenos Aires in Argentina. He completed his residency in neurology at Jackson Memorial Hospital in Miami, where he was chief resident in his final year. His fellowship in neuro-oncology was performed at Massachusetts General Hospital in Boston, as was his clinical research fellowship in neuro-oncology. About Dr. Voloschin Dr. Voloschin is a member of the American Academy of Neurology, the Society for Neuro-Oncology and the American Society of Clinical Oncology. He is board certified in neurology by the American Board of Psychiatry and Neurology and is board-certified in neuro-oncology by the United Council for Neurologic Subspecialties. He has extensive experience as principal investigator in several clinical trials, including investigator-initiated studies, for patients with malignant brain tumors. Dr. Voloschin also has delivered numerous lectures, trained junior physicians, published studies, presented at national scientific meetings and written book chapters on neuro-oncology. Dr. Voloschin is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Glioma, Astrocytoma, and Gliosarcoma. Dr. Voloschin is board certified in American Board Of Psychiatry And Neurology and United Council For Neurological Subspecialties - Neuro Oncology. Dr. Voloschin is currently accepting new patients.

Frequently Asked Questions about Dr. Tarek M. Mekhail

How do I make an appointment with Dr. Tarek M. Mekhail?

You can book an appointment with Dr. Tarek M. Mekhail by calling their office at 754-255-6741. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Tarek M. Mekhail a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Tarek M. Mekhail is classified as an Elite expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Tarek M. Mekhail specialize in?

While Dr. Tarek M. Mekhail is a Oncology, they have specific expertise in Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Tarek M. Mekhail participate in research or clinical trials?

Yes. Dr. Tarek M. Mekhail has published 48 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Tarek M. Mekhail's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Tarek M. Mekhail accept my insurance?

Dr. Tarek M. Mekhail accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 754-255-6741 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mekhail's expertise for a condition
ConditionClose
View All 19 Distinguished Conditions
View All 84 Advanced Conditions
View All 82 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile